Dyadic International Inc (DYAI)

[greenJack]

Hard to estimate a fair value for C1. Comparing it to the acquisition of Protein Services is easy but doesn’t make a lot of sense to me, the platform was very limited. Dividing the value of the C1 platform in the different markets they target, like mAbs, proteins, viral vectors within the human health and also the sectors in the animal health, could make more sense. If you take the animal health as one leg alone, it could be quickly valued at 1B+ after they start commercializing this year. If you start adding up the legs in the human health, it quickly adds up to somewhere between 5B and 10B.
Mark will not sell for 1.5B, it doesn’t make sense, it’s all accelerating now.